Aggregation behavior of polystyrene-nanoparticles in human blood serum and its impact on the in vivo distribution in mice

Journal of Nanomedicine and Nanotechnology

Volumn 5, Issue 2, 2014, Pages

  Mohr, Kristin ^a,c   Sommer, Maria ^b   Baier, Grit ^c   Schöttler, Susanne ^c   Okwieka, Patricia ^b,c   Tenzer, Stefan ^b   Landfester, Katharina ^c   Mailänder, Volker ^b,c   Schmidt, Manfred ^a   Meyer, Ralf Georg ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c MAX PLANCK INSTITUTE FOR POLYMER RESEARCH   (Germany)

Author keywords

Biodistribution; Human serum stability; Pre in vivo screening; Protein nanoparticle interaction; Surface functionalization

Indexed keywords

NANOPARTICLE; PLASMA PROTEIN; POLYSTYRENE;

ADSORPTION KINETICS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; CELL AGGREGATION; CELL INTERACTION; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; LIGHT SCATTERING; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; NORMAL HUMAN; ORGAN DISTRIBUTION; SCANNING ELECTRON MICROSCOPY; SERUM; SURFACE CHARGE; SYNTHESIS; ZETA POTENTIAL;

EID: 84901989812     PISSN: None     EISSN: 21577439     Source Type: Journal    
DOI: 10.4172/2157-7439.1000193     Document Type: Article

References (37)

1. Akhter S, Ahmad I, Ahmad MZ, Ramazani F, Singh A, et al. (2013) Nanomedicines as cancer therapeutics: current status. Curr Cancer Drug Targets 13: 362-378.
2. Zhu ZJ, Posati T, Moyano DF, Tang R, Yan B, et al. (2012) The interplay of monolayer structure and serum protein interactions on the cellular uptake of gold nanoparticles. Small 8: 2659-2663.
3. Walkey CD, Olsen JB, Guo H, Emili A, Chan WC (2012) Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J Am Chem Soc 134: 2139-2147.
4. Eberbeck D, Bergemann C, Wiekhorst F, Steinhoff U, Trahms L (2008) Quantification of specific bindings of biomolecules by magnetorelaxometry. J Nanobiotechnology 6: 4.
5. Tsai DH, Morris MD, DelRio FW, Guha S, Zachariah MR, et al. (2011) Quantitative determination of competitive molecular adsorption on gold nanoparticles using attenuated total reflectance-Fourier transform infrared spectroscopy. Langmuir 27(15): 9302-9313.
6. Walczyk D, Bombelli FB, Monopoli MP, Lynch L, Dawson KA (2010) What the cell "sees" in bionanoscience. J Am Chem Soc 132: 5761-5768.
7. Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE (2009) Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 61: 428-437.
8. Markovsky E, Baabur-Cohen H, Eldar-Boock A, Omer L, Tiram G, et al. (2012)Administration, distribution, metabolism and elimination of polymer therapeutics. J Control Release 161: 446-460.
9. Landfester K, Musyanovych A, Mailander V (2010) From Polymeric Particles to Multifunctional Nanocapsules for Biomedical Applications Using the Miniemulsion Process. Journal of Polymer Science Part a-Polymer Chemistry 48: 493-515.
10. Rausch K, Reuter A, Fischer K, Schmidt M (2010) Evaluation of nanoparticle aggregation in human blood serum. Biomacromolecules 11: 2836-2839.
11. Nikiforow I, Adams J, König AM, Langhoff A, Pohl K, et al. (2010) Selfstratification during film formation from latex blends driven by differences in collective diffusivity. Langmuir 26: 13162-13167.
12. Musyanovych A, Rossmanith R, Tontsch C, Landfester K (2007) Effect of hydrophilic comonomer and surfactant type on the colloidal stability and size distribution of carboxyl- and amino-functionalized polystyrene particles prepared by miniemulsion polymerization. Langmuir 23: 5367-5376.
13. Stepanek P (1993) Static and Dynamic Properties of Multiple Light-Scattering. Journal of Chemical Physics 99: 6384-6393.
14. Bantle S, Schmidt M, Burchard W (1982) Simultaneous Static and Dynamic Light-Scattering. Macromolecules 15: 1604-1609.
15. Meyer RG, Britten CM, Siepmann U, Petzold B, Sagban TA, et al. (2005) A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr). Cancer Immunol Immunother 54: 453-467.
16. Tenzer S, Docter D, Rosfa S, Wlodarski A, Kuharev J, et al. (2011) Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano 5: 7155-7167.
17. Distler U, Kuharev J, Navarro P, Levin Y, Schild H, et al. (2014) Drift timespecific collision energies enable deep-coverage data-independent acquisition proteomics. Nat Methods 11: 167-170.
18. Baumann D, Hofmann D, Nullmeier S, Panther P, Dietze C, et al. (2013) Complex encounters: nanoparticles in whole blood and their uptake into different types of white blood cells. Nanomedicine (Lond) 8: p. 699-713.
19. Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, et al. (2005) Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174: 6477-6489.
20. Böckenhoff K, Fischer WR (2001) Determination of electrokinetic charge with a particle-charge detector, and its relationship to the total charge. Fresenius J Anal Chem 371: 670-674.
21. Barenholz Y (2012) Doxil®--the first FDA-approved nano-drug: lessons learned. J Control Release 160: 117-134.
22. Rivera Gil P, Hühn D, del Mercato LL, Sasse D, Parak WJ, et al. (2010) Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds. Pharmacol Res 62: 115-125.
23. Joshi MD, Unger WJ, Storm G, van Kooyk Y, Mastrobattista E (2012) Targeting tumor antigens to dendritic cells using particulate carriers. J Control Release 161: 25-37.
24. Gaitanis A, Staal S (2010) Liposomal doxorubicin and nab-paclitaxel: nanoparticle cancer chemotherapy in current clinical use. Methods Mol Biol 624: 385-392.
25. Conner SD, Schmid SL (2003) Regulated portals of entry into the cell. Nature 422: 37-44.
26. Adjei IM, Peetla C, Labhasetwar V (2013) Heterogeneity in nanoparticles influences biodistribution and targeting. Nanomedicine (Lond) 422: 37-44.
27. Kodama T, Doi T, Suzuki H, Takahashi K, Wada Y, et al. (1996) Collagenous macrophage scavenger receptors. Curr Opin Lipidol 7: 287-291.
28. Krieger M, Herz J (1994) Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem 63: 601-637.
29. Laskin DL, Weinberger B, Laskin JD (2001) Functional heterogeneity in liver and lung macrophages. J Leukoc Biol 70: 163-170.
30. Neyen C, Plüddemann A, Mukhopadhyay S, Maniati E, Bossard M, et al. (2013) Macrophage scavenger receptor a promotes tumor progression in murine models of ovarian and pancreatic cancer. J Immunol 190: 3798-805.
31. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, et al. (2008) Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A 105: 14265-14270.
32. Anderson NL, Anderson NL (2012) The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1: 845-867.
33. Hirsjärvi S, Dufort S, Gravier J, Texier I, Yan Q, et al. (2013) Influence of size, surface coating and fine chemical composition on the in vitro reactivity and in vivo biodistribution of lipid nanocapsules versus lipid nanoemulsions in cancer models. Nanomedicine 9: 375-387.
34. Hofmann D, Mailander V (2013) Pharmacology of nanocarriers on the microscale: importance of uptake mechanisms and intracellular trafficking for efficient drug delivery. Nanomedicine (Lond) 8: 321-323.
35. Doshi N, Mitragotri S (2010) Macrophages recognize size and shape of their targets. PLoS One 5: e10051.
36. Champion JA, Walker A, Mitragotri S (2008) Role of particle size in phagocytosis of polymeric microspheres. Pharm Res 25: 1815-1821.
37. Bertrand N, Leroux JC (2012) The journey of a drug-carrier in the body: an anatomo-physiological perspective. J Control Release 161: 152-163.